Tc Biopharm Holdings Stock Buy Hold or Sell Recommendation
| TCBP Stock | USD 1.73 0.04 2.37% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding TC BioPharm Holdings is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell TC BioPharm Holdings within the specified time frame.
Check out TC BioPharm Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as TCBP and provide practical buy, sell, or hold advice based on investors' constraints. TC BioPharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
TCBP |
Execute TC BioPharm Buy or Sell Advice
The TCBP recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on TC BioPharm Holdings. Macroaxis does not own or have any residual interests in TC BioPharm Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute TC BioPharm's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
TC BioPharm Trading Alerts and Improvement Suggestions
| TC BioPharm Holdings generated a negative expected return over the last 90 days | |
| TC BioPharm Holdings has high historical volatility and very poor performance | |
| TC BioPharm Holdings may become a speculative penny stock | |
| TC BioPharm Holdings has a very high chance of going through financial distress in the upcoming years | |
| TC BioPharm Holdings currently holds 1.8 M in liabilities. TC BioPharm Holdings has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about TC BioPharm's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (5.91 M) with profit before overhead, payroll, taxes, and interest of 3.84 M. | |
| TC BioPharm Holdings currently holds about 1.57 M in cash with (10.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| TC BioPharm Holdings has a very weak financial position based on the latest SEC disclosures |
TC BioPharm Returns Distribution Density
The distribution of TC BioPharm's historical returns is an attempt to chart the uncertainty of TC BioPharm's future price movements. The chart of the probability distribution of TC BioPharm daily returns describes the distribution of returns around its average expected value. We use TC BioPharm Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of TC BioPharm returns is essential to provide solid investment advice for TC BioPharm.
| Mean Return | -2.13 | Value At Risk | -14.96 | Potential Upside | 13.65 | Standard Deviation | 10.49 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of TC BioPharm historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
TC BioPharm Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to TC BioPharm or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that TC BioPharm's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a TCBP stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -2.27 | |
β | Beta against Dow Jones | -1.18 | |
σ | Overall volatility | 10.49 | |
Ir | Information ratio | -0.19 |
TC BioPharm Volatility Alert
TC BioPharm Holdings is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure TC BioPharm's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact TC BioPharm's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.TC BioPharm Fundamentals Vs Peers
Comparing TC BioPharm's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze TC BioPharm's direct or indirect competition across all of the common fundamentals between TC BioPharm and the related equities. This way, we can detect undervalued stocks with similar characteristics as TC BioPharm or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of TC BioPharm's fundamental indicators could also be used in its relative valuation, which is a method of valuing TC BioPharm by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare TC BioPharm to competition |
| Fundamentals | TC BioPharm | Peer Average |
| Return On Equity | -12.17 | -0.31 |
| Return On Asset | -1.09 | -0.14 |
| Current Valuation | 1.71 M | 16.62 B |
| Shares Outstanding | 572.02 K | 571.82 M |
| Shares Owned By Institutions | 1.76 % | 39.21 % |
| Number Of Shares Shorted | 128.4 K | 4.71 M |
| Price To Book | 0.34 X | 9.51 X |
| Price To Sales | 0.51 X | 11.42 X |
| Gross Profit | 3.84 M | 27.38 B |
| EBITDA | (13.61 M) | 3.9 B |
| Net Income | (5.91 M) | 570.98 M |
| Cash And Equivalents | 1.57 M | 2.7 B |
| Cash Per Share | 0.08 X | 5.01 X |
| Total Debt | 1.8 M | 5.32 B |
| Current Ratio | 0.19 X | 2.16 X |
| Book Value Per Share | 3.38 X | 1.93 K |
| Cash Flow From Operations | (10.54 M) | 971.22 M |
| Short Ratio | 0.05 X | 4.00 X |
| Earnings Per Share | (192.95) X | 3.12 X |
| Target Price | 140.0 | |
| Number Of Employees | 41 | 18.84 K |
| Beta | 0.25 | -0.15 |
| Market Capitalization | 360.37 K | 19.03 B |
| Total Asset | 8.93 M | 29.47 B |
| Retained Earnings | (38.84 M) | 9.33 B |
| Working Capital | 950.33 K | 1.48 B |
| Net Asset | 8.93 M |
Note: Acquisition by Randall Mark Edward of 70000 shares of TC BioPharm subject to Rule 16b-3 [view details]
TC BioPharm Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as TCBP . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About TC BioPharm Buy or Sell Advice
When is the right time to buy or sell TC BioPharm Holdings? Buying financial instruments such as TCBP Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having TC BioPharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Municipals ETFs Thematic Idea Now
Broad Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for TCBP Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.